Expanded Access Programs
Marken transports and delivers investigational medical products that have not yet been approved by the FDA for use by patients who face a life-threatening illness and who receive special exemptions for the unapproved treatments.
These therapies are sometimes referred to as “early access programs” or “compassionate use,” and the transport of these products are extremely time and temperature sensitive.
Our capabilities to assist in expanded access programs include:
- End-to-end visibility through our suite of tracking and monitoring technology
- Flexibility to manage complex supply chains and routings at a short notice
- Safeguard the integrity of the product throughout the journey
- Adhere to various ethical and regulatory standards while meeting the needs of the patient